EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis

Emine A Rahiman, Rajendra Prasad Anne iD, Rajasekharan P Warrier

International Journal of Neonatal Screening · 25.02.2026 · 12 (1) · 10

DOI: 10.3390/ijns12010010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 25.02.2026. Verfasst von Emine A Rahiman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening helps identify sickle cell disorder (SCD) early and to promptly initiate effective measures. It is estimated that India accounts for approximately 16% of global annual births with SCD. Multiple reports of screening for SCD in India have emerged in the last decade. Our aim was to pool the birth prevalence of SCD and sickle cell trait (SCT). A systematic review of published evidence on nontargeted, universal screening for SCD or SCT in newborns was performed (16 studies). The pooled prevalence of SCD was 1100 per 100,000 (10 studies, 88,276 neonates, 95% CI: 432, 1768), while that of SCT was 9639 per 100,000 (7 studies, 72,702 neonates, 95% CI: 6283, 12,995) in endemic regions. Limited data exist from nonendemic regions. Only three studies had data on follow-up and confirmatory genetic diagnosis. Sparse data exist on cost-effectiveness, long-term follow-up, and the impact of early screening on mortality. Concerted ongoing efforts in the identification of the burden are needed. The needs of the hour are universalization of NBS, integration into existing health systems, and maintenance of birth cohorts with early introduction of penicillin prophylaxis, hydroxyurea, parental education, appropriate immunization, and continued follow-up by an experienced medical team.

Schlagwörter

Stichwörter der Autor:innen

SDG 4hydroxyureapreventive caretribal healthunder-5 mortality

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.
  • Department of Neonatology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Pediatric Hematology Oncology, Ochsner Children's Hospital, New Orleans, LA 70121, USA.

ORCID-Profile: Rajendra Prasad Anne

Zitieren

APA

Rahiman, E. A., Anne, R. P., & Warrier, R. P. (2026). Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis. International Journal of Neonatal Screening, 12(1), 10. https://doi.org/10.3390/ijns12010010

Vancouver

Rahiman EA, Anne RP, Warrier RP. Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis. International Journal of Neonatal Screening. 2026;12(1):10. doi:10.3390/ijns12010010

BibTeX
@article{Rahiman2026,
  author = {Rahiman, Emine A and Anne, Rajendra Prasad and Warrier, Rajasekharan P},
  title = {Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Neonatal Screening},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {10},
  doi = {10.3390/ijns12010010}
}
Kostenlos starten →